Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/BGLA stock hub

FRA/BGLA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/BGLAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/BGLAFRA/BGLA

—

Loading chart…

In the news

Latest news · FRA/BGLA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.4

P25 n/aP50 n/aP75 n/a

Trailing P/E39

P25 n/aP50 n/aP75 n/a

ROE21.9

P25 n/aP50 n/aP75 n/a

ROIC68.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/BGLA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

SEK

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	DE
Employees	242
Employees Change	16%
Employees Change Percent	7.21
Enterprise value	EUR 1.1B
Exchange	Frankfurt Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 1.2B
Price	EUR 11.49
Price currency	EUR
Rev Per Employee	587,318.51x
Sic	2834
Symbol	fra/BGLA
Website	https://www.biogaiagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.56%
EV Earnings	36.7x
EV/EBIT	27.11x
EV/EBITDA	25.7x
EV/FCF	40.3x
EV/Sales	7.97x
FCF yield	2.33%
Forward P/E	29.4x
P/B ratio	9.88x
P/E ratio	39.03x
P/S ratio	8.44x
PE Ratio10 Y	35.46x
PE Ratio3 Y	31.07x
PE Ratio5 Y	35.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.38%
EBITDA Margin	30.49%
FCF margin	19.7%
Gross margin	73.37%
Gross Profit	EUR 104.3M
Gross Profit Growth	9.49%
Gross Profit Growth Q	25.25%
Gross Profit Growth3 Y	12.06%
Gross Profit Growth5 Y	15.59%
Net Income	EUR 30.7M
Net Income Growth	-5.3%
Net Income Growth Q	20.56%
Net Income Growth3 Y	-3.8%
Net Income Growth5 Y	13.11%
Pretax Margin	27.38%
Profit Margin	21.63%
Profit Per Employee	EUR 127,059
ROA	15.56
Roa5y	11.62
ROCE	32.31
ROE	21.91
Roe5y	17.83
ROIC	68.07
Roic5y	63.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.61%
Cagr15y	14.26%
Cagr1y	33.73%
Cagr20y	19.48%
Cagr3y	15.22%
Cagr5y	9.29%
Div CAGR10	13.09%
Div CAGR3	12.5%
Div CAGR5	40.62%
EPS Growth	-5.38
EPS Growth Q	21.2
EPS Growth3 Y	-3.84
EPS Growth5 Y	10.32
FCF Growth	-15.7%
FCF Growth Q	-18.96%
FCF Growth3 Y	0.22%
FCF Growth5 Y	8.11%
OCF Growth	-17.86%
OCF Growth Q	-18.23%
OCF Growth10 Y	10.06%
OCF Growth3 Y	-1.31%
OCF Growth5 Y	6.74%
Revenue Growth	8.12x
Revenue Growth Q	20.76x
Revenue Growth3 Y	11.69x
Revenue Growth5 Y	15.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.85
Assets	EUR 147.6M
Cash	EUR 74M
Current Assets	EUR 112.2M
Current Liabilities	EUR 18.3M
Debt	EUR 2.1M
Debt EBITDA	EUR 0.05
Debt Equity	EUR 0.02
Debt FCF	EUR 0.08
Equity	EUR 121.4M
Interest Coverage	74.62
Liabilities	EUR 26.2M
Long Term Assets	EUR 35.5M
Long Term Liabilities	EUR 7.9M
Net Cash	EUR 71.9M
Net Cash By Market Cap	EUR 5.99
Net Cash Growth	-34.86%
Net Debt EBITDA	EUR -1.66
Net Debt Equity	EUR -0.59
Net Debt FCF	EUR -2.57
Tangible Book Value	EUR 107.8M
Tangible Book Value Per Share	EUR 1.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.12
Inventory Turnover	2.56
Net Working Capital	EUR 20.8M
Quick ratio	5.21
Working Capital	EUR 94.2M
Working Capital Turnover	EUR 0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend Growth	-41.77%
Dividend Growth Years	2%
Dividend per share	EUR 0.37
Dividend Years	18
Dividend Yield	3.21%
Ex Div Date	2026-05-08
Last Dividend	EUR 0.37
Payout Frequency	Annual
Payout Ratio	59.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	258.22%
1Y total return	33.7%
200-day SMA	9.71
3Y total return	52.96%
50-day SMA	10.63
50-day SMA vs 200-day SMA	50over200
5Y total return	55.91%
All Time High	12
All Time High Change	-4.25%
All Time High Date	2025-02-04
All Time Low	0.08
All Time Low Change	13,578.57%
All Time Low Date	2002-09-25
ATR	0.17
Ch YTD	18.88
High	11.49
High52	11.49
High52 Date	2026-05-08
High52ch	0%
Low	11.49
Low52	8.38
Low52 Date	2025-08-14
Low52ch	37.11%
Ma50ch	8.14%
Price vs 200-day SMA	18.28%
RSI	63.78
RSI Monthly	61.39
RSI Weekly	67.2
Sharpe ratio	0.85x
Sortino ratio	1.48
Total Return	3.12%
Tr YTD	22.87
Tr15y	638.35%
Tr1m	11.72%
Tr1w	8.06%
Tr3m	16.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 41.8M
Operating Income Growth	-1.85
Operating Income Growth Q	-10.52
Operating Income Growth3 Y	10.55
Operating Income Growth5 Y	13.08
Operating margin	29.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	84,119,306%
Net Borrowing	-630,011.4
Shares Insiders	5.52%
Shares Institutions	35.79%
Shares Qo Q	0%
Shares Yo Y	0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 28M
Average Volume	11.5x
Bv Per Share	1.2
CAPEX	EUR -325,628
Ch10y	159.2
Ch15y	357.2
Ch1m	8.09
Ch1w	4.55
Ch1y	20.76
Ch20y	2,019.9
Ch3m	12.87
Ch3y	25.99
Ch5y	25.16
Ch6m	31.16
Change	4.63%
Change From Open	0
Close	10.98
Days Gap	4.63
Depreciation Amortization	1,559,064.2
Earnings Date	2026-05-07
EBIT	EUR 41.8M
EBITDA	EUR 43.3M
EPS	EUR 0.3
F Score	5
FCF	EUR 28M
FCF EV Yield	2.48x
Financing CF	-65,593,721
Fiscal Year End	December
Founded	1,990
Goodwill	13,479,501.4
Graham Number	2.77479
Graham Upside	-75.85
Income Tax	EUR 8.2M
Investing CF	-308,903
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Last Split Date	2022-05-18
Last Split Type	Forward
Lynch Fair Value	EUR 3.86
Lynch Upside	-66.41
Ma150	9.94
Ma150ch	15.65%
Ma20	11
Ma20ch	4.45%
Net CF	-39,056,275
Next Earnings Date	2026-07-17
Open	11.49
P FCF Ratio	42.86
P OCF Ratio	42.37
Payment Date	2026-05-15
Ppne	16,668,111.6
Price Date	2026-05-08
Price EBITDA	EUR 27.7
Ptbv Ratio	11.13
Relative Volume	1.74x
Revenue	142,131,079x
Tax By Revenue	5.75x
Tax Rate	21%
Tr20y	3,412.71%
Tr6m	35.57%
Z Score	25.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/BGLA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.2%

$0.37 annual per share

Payout ratio

+59.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+40.6%

2 consecutive years of growth

Total shareholder yield

+3.1%

Next ex-dividend date: 2026-05-08

Performance

FRA/BGLA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/BGLA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.8%

Share of float held by funds and institutions

Insider ownership

+5.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/BGLA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.8

Neutral momentum band

Price vs 200-day MA

+18.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/BGLA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/BGLA stock rating?

fra/BGLA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/BGLA analysis?

The full report lives at /stocks/fra/BGLA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/BGLA?

The latest report frames fra/BGLA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/BGLA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.